Takefumi Kishimori
4PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 06, 2026
Oral semaglutide and survival in heart failure with preserved ejection fraction and type 2 diabetes.Takefumi Kishimori, Takao Kato, Yoshihiro Iwasaki
|Nov 05, 2025
Combination therapy with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in heart failure patients with type 2 diabetes.Takefumi Kishimori, Takao Kato, Atsuyuki Wada
|Jul 17, 2025
Cardiovascular outcomes and safety of semaglutide in non-overweight populations with type 2 diabetes: a comparison with dipeptidyl peptidase 4 inhibitors.Takefumi Kishimori, Takao Kato, Atsuyuki Wada
|Jul 08, 2025
Effectiveness of semaglutide on survival outcomes in patients with type 2 diabetes and chronic kidney disease.Takefumi Kishimori, Takao Kato, Atsuyuki Wada
Pageof 1
